A member of the Brown faculty since 2003, Ali Yalcindag, MD is a graduate of Cerrahpasa Faculty of Medicine of Istanbul University. After completing a residency in Pediatrics at NYU Medical Center, he completed a fellowship in the Division of Immunology at Boston Children’s Hospital. Currently, he is the Director of Division of Pediatric Rheumatology at Hasbro Children’s Hospital.
| Pathania S, Rehman R, Ward M, Yalcindag A, Ross A, Herzlinger M, Gorbounova I. "An unusual case of pediatric granulomatosis with polyangiitis complicated by splenic infarction presenting as inflammatory bowel disease." JPGN reports, vol. 5, no. 3, 2024, pp. 398-401. |
| Goel AR, Yalcindag A. "An Update on Kawasaki Disease." Current Rheumatology Reports, vol. 27, no. 1, 2024, pp. 4. |
| Bryant MC, Massingham LJ, Yalcindag A. "Inflammatory Arthritis in a 19-month-old with Von Hippel-Lindau Disease." Rhode Island medical journal (2013), vol. 106, no. 5, 2023, pp. 30-33. |
| Bryant MC, Spencer LT, Yalcindag A. "A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature." Pediatric rheumatology online journal, vol. 20, no. 1, 2022, pp. 65. |
| Bryant MC, Terry Spencer L, Yalcindag A. "Letter to the editor: Response to "COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis" by Batu et al." Seminars in Arthritis and Rheumatism, vol. 57, 2022, pp. 152092. |
| Goel AR, Chiang SS, Ibrahim O, Yalcindag A. "Multisystem Inflammatory Syndrome in an Adolescent Following SARS-CoV-2 Exposure Despite Three Doses of a COVID-19 Vaccine." Rhode Island medical journal (2013), vol. 105, no. 5, 2022, pp. 41-45. |
| Oliva, Rocio, Ibrahim, Osama, McCormick, Winston, Yalcindag, Ali, Dennehy, Penelope. "Retropharyngeal involvement in multisystem inflammatory syndrome in children: Case report and review of literature." SAGE Open Medical Case Reports, vol. 10, 2022, pp. 2050313X2211283. |
| Choe YJ, Blatt DB, Yalcindag A, Geffert SF, Bobenchik AM, Michelow IC. "Cryptococcus albidus Fungemia in an Immunosuppressed Child: Case Report and Systematic Literature Review." Journal of the Pediatric Infectious Diseases Society, vol. 9, no. 1, 2020, pp. 100-105. |
| Hsieh, Jackie, Yalcindag, Ali, Coghlin, Daniel T. "A Sweet Case of Mycoplasma." Pediatrics, vol. 140, no. 3, 2017, pp. e20162762. |
| Hodax, Juanita K., Bialo, Shara R., Yalcindag, Ali. "SIADH in Systemic JIA Resolving After Treatment With an IL-6 Inhibitor." Pediatrics, vol. 141, no. 1, 2017, pp. e20164174. |
| Mina, Rina, von Scheven, Emily, Ardoin, Stacy P., Eberhard, B. Anne, Punaro, Marilynn, Ilowite, Norman, Hsu, Joyce, Klein-gitelman, Marisa, Moorthy, L. Nandini, Muscal, Eyal, Radhakrishna, Suhas M., Wagner-weiner, Linda, Adams, Matthew, Blier, Peter, Buckley, Lenore, Chalom, Elizabeth, Chédeville, Gaëlle, Eichenfield, Andrew, Fish, Natalya, Henrickson, Michael, Hersh, Aimee O., Hollister, Roger, Jones, Olcay, Jung, Lawrence, Levy, Deborah, Lopez-Benitez, Jorge, McCurdy, Deborah, Miettunen, Paivi M., Quintero-Del Rio, Ana I., Rothman, Deborah, Rullo, Ornella, Ruth, Natasha, Schanberg, Laura E., Silverman, Earl, Singer, Nora G., Soep, Jennifer, Syed, Reema, Vogler, Larry B., Yalcindag, Ali, Yildirim-toruner, Cagri, Wallace, Carol A., Brunner, Hermine I. "Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus." Arthritis Care & Research, vol. 64, no. 3, 2012, pp. 375-383. |
| YALCINDAG, A, HE, R, LAOUINI, D, ALENIUS, H, CARROLL, M, OETTGEN, H, GEHA, R. "The complement component C3 plays a critical role in both TH1 and TH2 responses to antigen." Journal of Allergy and Clinical Immunology, vol. 117, no. 6, 2006, pp. 1455-1461. |
| Laouini, Dhafer, ElKhal, Abdala, Yalcindag, Ali, Kawamoto, Seiji, Oettgen, Hans, Geha, Raif S. "COX-2 inhibition enhances the TH2 immune response to epicutaneous sensitization." Journal of Allergy and Clinical Immunology, vol. 116, no. 2, 2005, pp. 390-396. |
| Kawamoto S, Yalcindag A, Laouini D, Brodeur S, Bryce P, Lu B, Humbles AA, Oettgen H, Gerard C, Geha RS. "The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen." Journal of Clinical Investigation, vol. 114, no. 3, 2004, pp. 399-407. |
| Laouini, Dhafer, Kawamoto, Seiji, Yalcindag, Ali, Bryce, Paul, Mizoguchi, Emiko, Oettgen, Hans, Geha, Raif S. "Epicutaneous sensitization with superantigen induces allergic skin inflammation." Journal of Allergy and Clinical Immunology, vol. 112, no. 5, 2003, pp. 981-987. |
| Fisler, Rita E., Liang, Marilyn G., Fuhlbrigge, Robert C., Yalcindag, Ali, Sundel, Robert P. "Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis." Journal of the American Academy of Dermatology, vol. 47, no. 4, 2002, pp. 505-511. |
| Ma W, Bryce PJ, Humbles AA, Laouini D, Yalcindag A, Alenius H, Friend DS, Oettgen HC, Gerard C, Geha RS. "CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation." Journal of Clinical Investigation, vol. 109, no. 5, 2002, pp. 621-8. |
| Yalcindag A, Sundel R. "Vasculitis in childhood." Current opinion in rheumatology, vol. 13, no. 5, 2001, pp. 422-7. |
My earlier research focused on a mouse model of atopic dermatitis, a condition characterized by chronic allergic inflammation of skin. Using a mouse model that mimics human atopic dermatitis developed in the laboratory of Dr. Raif Geha at Boston Children's Hospital, I tried to identify the mechanisms by which the immune sytem responds to substances introduced through the skin. Specifically, I studied the role of substances called complements in directing and changing the immune response.
My current clinical reasearch interest is in the area of pediatric rheumatology. I serve as the site PI for the multicenter collaborative registry (CARRA Registry). The CARRA Registry is an observational study that enrolls children and adolescents with major rheumatic diseases followed at participating study sites. The original "Legacy" CARRA Registry is now complete and enrolled 9587 patients.
Using a mouse model of atopic dermatitis, I studied the role of complement proteins and their recptors in modulating the immune response. I demonstrated that the complement proteinn C3a downregulates the Th2 response to epicutaneously introduced antigens suggesting an important role for complement proteins in T cell polarization. Furthermore, I conducted experiments to show that C3 is important for both Th1 and Th2 immune responses.
In the original CARRA registry, we collected data on children followed by Hasbro Children's Hopsital Rheumatology clinic. The new CARRA Registry started enrolling patients in the summer of 2015. Continuation of the CARRA Registry will support data collection on patients with pediatric-onset rheumatic diseases and will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions. Our site got activated in April 2016.
Yalcindag A, Bloom BJ, Alario AJ. Rheumatic Disorders, Book Chapter in Practical Guide to The Care of the Pediatric Patient. 2nd ed 2008
Yalcindag A, Sundel R. Serum Sickness. Book chapter in Current Pediatric Therapy, 17th ed, 2002.
| Year | Degree | Institution |
|---|---|---|
| 1994 | MD | Istanbul University |
American Academy of Pediatrics
American College of Rheumatology
American Medical Association
Childhood Arthritis and Rheumatology Research Alliance (CARRA)
| Division Director. Hasbro Children's Hospital, 2010-Present |
